The Joe Rogan ExperienceJoe Rogan Experience #2002 - Amanda Feilding
CHAPTERS
- 0:00 – 1:48
Welcoming Amanda Feilding and framing her psychedelic legacy
Joe Rogan opens by thanking Amanda Feilding and highlighting how unusual it was to pursue psychedelic research when it was culturally and legally controversial. Amanda notes her early timing—when psychedelics were still associated with discovery and fun—set the stage for her lifelong work.
- •Joe praises Feilding’s impact and persistence in psychedelic research
- •Amanda contrasts early-era psychedelic exploration with later repression
- •Conversation sets a tone of science, history, and consciousness exploration
- 1:48 – 5:30
Childhood roots: isolation, spirituality, and early mystical curiosity
Feilding describes an unconventional, isolated upbringing and a close bond with her diabetic, eccentric father—whom she ‘cared for’ from age three. She explains how Catholicism, agnosticism, and a Buddhist influence shaped an early fascination with mysticism and altered states.
- •Early caretaking role and closeness with her father
- •Three spiritual influences: Catholic mother, agnostic father, Buddhist godfather
- •Mystical experiences and imaginative inner life in a remote setting
- 5:30 – 6:25
Leaving convent school at 16 and seeking Buddhism and self-education
Feilding recounts attending a convent/boarding school, excelling academically, but rejecting the constraints—especially the refusal to let her study Buddhism. She left school at 16, choosing independent learning over institutional boundaries.
- •Boarding school/convent experience and dissatisfaction
- •Conflict over access to Buddhist texts
- •Decision to leave school early and self-educate
- 6:25 – 9:23
Religion, incense, and the idea of psychedelics at the roots of Christianity
The conversation turns to church ritual and altered states, including incense and the Eucharist as potentially psychoactive in origin. Rogan references Allegro’s 'The Sacred Mushroom and the Cross,' and Feilding agrees psychedelics likely underpinned many ancient spiritual ceremonies.
- •Incense, chanting, and ritual as gateways to mystical states
- •Claim that early sacred ‘host’ practices may have been psychedelic
- •Discussion of Allegro, Dead Sea Scrolls interpretations, and fertility rites
- 9:23 – 12:27
First cannabis experience, Oxford influences, and tutoring under Zaehner
Feilding describes first using cannabis at 16 and the way it transformed music and perception. At Oxford, she connects with older, war-experienced students and studies comparative religion and mysticism with Professor Zaehner—whose skepticism about psychedelic mysticism becomes a key point of debate.
- •First cannabis experience and heightened appreciation of music
- •Oxford social circle and intellectual discovery
- •Mentorship with Professor Zaehner and disagreement about ‘drug’ vs ‘endogenous’ mysticism
- 12:27 – 22:12
Ego, language, and Feilding’s blood-flow theory of consciousness
Feilding explains her long-running hypothesis linking human evolution, upright posture, cerebral blood flow, and the rise of ego and language. She argues psychedelics relax ego control and increase sensory connectivity, potentially rebalancing modern disconnection from nature and embodied experience.
- •Upright posture and gravity’s effect on cerebral blood dynamics
- •Language and ego as a blood-distribution/control mechanism
- •Psychedelics as ego-loosening tools that increase sensory connectivity
- •Modern risk: narratives and ‘screen reality’ replacing direct experience
- 22:12 – 26:47
Ancient art and mystery cults: Chauvet caves, Eleusis, and cultural “rings”
Using Chauvet cave paintings and the Eleusinian Mysteries, Feilding argues altered states were central to humanity’s greatest creative and spiritual peaks. She describes civilization as having growth ‘rings,’ where cultures infused with altered states produce extraordinary art and insight.
- •Chauvet’s realism and movement as evidence of ‘spiritual’ context
- •Speculation about drumming/singing vs substances in prehistory
- •Eleusinian Mysteries, ergot, and scholarship like 'The Immortality Key'
- •Claim that classical education often omits the role of mystery traditions
- 26:47 – 29:35
The drug war’s ‘lost decades’ and the strategy to change policy through science
Rogan and Feilding discuss the crackdown after 1970, the halt in research, and the human cost of criminalization and incarceration. Feilding explains why the Beckley Foundation pursued a dual strategy: produce credible science and use it to reform policy—despite a Catch-22 of restricted access.
- •Schedule I restrictions ended research and expanded incarceration
- •Disproportionate harms to minorities and ongoing imprisonments
- •Beckley Foundation’s mission: research + policy reform as linked goals
- •MAPS/MDMA PTSD work as a politically persuasive breakthrough
- 29:35 – 32:43
Neuroimaging breakthrough: default mode network, depression, and the mystical predictor
Feilding describes the Beckley-Imperial psilocybin imaging work and what it revealed: decreased blood flow/activity in the default mode network (linked to ego). She argues that the intensity of the mystical-type experience predicts better therapeutic outcomes in depression, turning ‘spirituality’ into a measurable clinical factor.
- •Why psilocybin was chosen first (less taboo than LSD)
- •Imaging results: reduced activity/blood flow in the DMN
- •DMN hyperactivity as a feature of depression/anxiety/addiction
- •Mystical experience as a key mediator of lasting symptom relief
- 32:43 – 38:23
Microdosing and medical frontiers: Alzheimer’s, autism, Parkinson’s, migraines, and cannabis
The discussion expands beyond psychotherapy to microdosing as a potential tool for neurodegenerative and developmental conditions. Feilding shares anecdotal-but-striking cases (Alzheimer’s lucidity after LSD microdose), study plans (autism, ibogaine for Parkinson’s), and aligns this with dramatic cannabis examples (Parkinson’s tremor reduction).
- •Microdosing LSD as a possible ‘connectivity spark’ in Alzheimer’s
- •Autism study ambitions and reports of benefits at milder levels
- •Interest in ibogaine microdosing for Parkinson’s symptoms
- •Cannabis oil examples (Parkinson’s) and broader medical potential
- 38:23 – 53:41
How psychedelics might work: blood, vasoconstriction models, glucose, and connectivity maps
Feilding revisits mechanistic ideas: psychedelics as vasoconstrictors that shift blood into capillaries, altering cerebral spinal fluid dynamics and brain energy availability. Rogan and Feilding discuss metabolic fuel (glucose vs ketones) and show network maps demonstrating increased inter-regional connectivity under psychedelics.
- •Bart/Hypothesis: vascular dynamics, capillaries, CSF displacement
- •‘More energy’ model: oxygen/glucose enabling wider brain co-activation
- •Brain connectivity imagery: denser cross-talk under psychedelics
- •Discussion of ketogenic fuel and ongoing unknowns in mechanism
- 53:41 – 1:15:01
Trepanation: ancient practice, modern hypothesis, and why she wants research not hype
Feilding explains trepanation (drilling a hole in the skull) as an ancient, globally distributed practice often linked to religion and healing. She emphasizes her interest is research-based: trepanation may restore cranial pulsation/compliance and help headaches or mental conditions, but needs rigorous study and ethical approvals.
- •Trepanation’s prehistory, global spread, and religious associations
- •Hypothesis: restoring pulsation/cranial compliance closer to childhood
- •Clinical angle: migraines/headaches as historically cited indications
- •Practical research case: hospitals already trepan routinely in neurosurgery
- 1:15:01 – 2:09:56
Self-trepanation story: motivations, method, subtle effects, and ‘bad optics’
Rogan asks about Feilding’s own trepanation in her 20s; she describes years searching for a doctor, then carefully doing it herself and filming it—while discouraging others from copying. She reports subtle changes (quieted inner chatter, fewer anxious dreams) but underscores that without controlled research, claims should remain cautious.
- •Why she did it: belief in the hypothesis and observed effects in others
- •How she prepared (tools, technique, safety concerns) and filmed it
- •Reported aftereffects: ‘tide coming in,’ reduced anxious dreaming
- •Refusal to release footage widely to avoid copycat self-surgery
- 2:09:56 – 2:29:39
DMT entities, bad trips, near-death chemistry, telepathy, and anomalous experiences
The conversation moves into the strange edge: entity encounters, why DMT differs from LSD, and how near-death states might produce endogenous psychedelic-like chemistry. Feilding shares experiences suggesting telepathy is real (notably with her beloved pigeon Bertie) and argues mystical/anomalous experiences may become scientifically investigable with better tools.
- •Entities: stronger in DMT/psilocybin, less in LSD; differing ‘feel’ and palette
- •Bad trips as ‘pathways’—fear memory shaping later experiences
- •Near-death experiences and endogenous releases (DMT, serotonin, oxytocin, etc.)
- •Telepathy stories and hypothesis that ego/noise suppresses subtle perception
- 2:29:39 – 2:35:45
Closing vision: democratized access, ethical commercialization, and supporting Beckley’s work
Feilding and Rogan end on the need for legal access, funding, and ethical frameworks so psychedelic benefits aren’t restricted to the wealthy. They discuss philanthropy’s role, concerns about monopolies and pricing, and direct listeners to the Beckley Foundation to learn more and donate.
- •Psychedelics as both medicine and ‘elixir’ for human flourishing
- •Need for policy reform, faster research pipelines, and broader access
- •Concerns about profit, monopolies, and affordability
- •Beckley Foundation website and donation options to support research
